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General medical illnesses, severe enough to necessitate hospitalisation, 
are known to have profound impacts on individuals, families, 
communities and healthcare services. Inpatient mortality and 
acute functional declines aside, hospitalised medical patients post 
discharge are known to have higher 12-month mortality rates1 and 
be at increased risk for progressive functional declines. Families 
are burdened with long-term care-giving responsibilities and the 
financial implications of employment loss. In addition ‘hospitalisation 
begets hospitalisation’ and already overburdened health services face 
the increased utilisation of resources through hospital readmissions 
or outpatient visits. Furthermore, the high burden of illness in 
the setting of a country faced with the dual epidemics of human 
immunodeficiency virus (HIV) and chronic diseases of lifestyle 
places constant pressure on the optimal utilisation of acute hospital 
beds. Detailed short-, intermediate- and long-term follow-up and 
outcomes data are crucial to a better understanding of these impacts, 
and to inform patients, healthcare workers and policy makers. 
Short-term outcomes, such as inpatient mortality and acute 
functional decline following hospitalisation, have been extensively 
studied and are well established for a number of medical illnesses 
in both developed and developing country settings. However, few 
data are available on the intermediate- and long-term outcomes of 
general medical hospital admissions, especially in developing country 
settings where documentation and follow-up are problematic. To our 
knowledge, and despite the fact that the majority of African hospitals 
provide generalist secondary-level medical services, there are no 
intermediate-term outcome studies of general medical cohorts from 
high HIV-prevalent developing countries. Studies from developed 
country settings are largely restricted to elderly or intensive care 
unit (ICU) cohorts1 with low HIV prevalence, or to specific medical 
conditions (e.g. ischaemic heart disease2 or cerebrovascular disease3 
and their disease-specific outcomes). The South African healthcare 
context is unique. With intersecting burdens of communicable and 
non-communicable disease, we aimed to conduct a 12-month follow-
up study of a cohort of hospitalised, medical inpatients admitted to a 
tertiary South African hospital.  
Methods 
Study population
Our study population consisted of 465 patients admitted to the acute 
general medical wards at Groote Schuur Hospital (GSH), Cape Town, 
between 14 September and 16 November 2009. During the 9-week 
study period all patients aged >16 years, referred from either the 
emergency unit or a district-level hospital to GSH, were eligible for 
inclusion and enrolled. Patients directly admitted to the ICU, those 
with acute coronary syndromes, patients admitted to palliative care 
beds (where death is anticipated within 48 hours of admission) and 
those admitted to the ‘short-stay ward’ (where patients are admitted 
with predominantly chronic disease and have an anticipated hospital 
stay <48 hours) were excluded. Verbal consent was obtained from all 
patients and the study received ethics approval from the University 
of Cape Town Human Research Ethics Committee. On admission, 
all baseline demographic and clinical information and pre-admission 
functionality data were collected. After discharge, folders underwent 
blinded review to document discharge diagnoses and identify patients 
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Objectives. Hospitalisation for medical illness has ongoing impact 
on individuals, healthcare services and society beyond discharge. 
This study’s objective was to determine the 12-month mortality 
and functional outcomes of patients admitted to the acute medical 
service at Groote Schuur Hospital (GSH).
Methods. Follow-up, using the hospital records system and 
provincial death registry, together with telephonic interviews or 
home visits, was attempted for 465 medical inpatients admitted to 
GSH between 14 September and 16 November 2009. Functional 
outcomes were assessed using the Katz activities of daily living 
(ADL) score and Barthel index (BI).
Outcome measures. The major study outcomes included: 
12-month mortality (overall and unexpected), changes in functional 
status and pre- and post-admission employment rates.
Results. Inpatient mortality was 11%. At 12-month follow-up, 35% 
(145/415) were deceased and 30% (125/415) could not be traced; 
38% (55/145) of deaths were considered expected and unexpected 
mortality was associated with age >40 years (p=0.02) and an 
admission urea >7.0 mmol/l (p=0.004). Katz ADL deteriorated 
in 15% (21/143) of interviewed patients and was associated with 
age >50 years (p=0.005); 23% (33/143) had improved Katz ADL 
associated with admission human immunodeficiency virus (HIV) 
(p=0.01), tuberculosis (TB) infection (p=0.05) and sepsis (p=0.02). 
Employment rates declined from 41% (59/145) pre-admission to 
18% (26/145) at 12 months (p<0.001), with little increase in the 
number of persons receiving disability grants. Twenty per cent 
(29/145) of patients required hospital readmission and this was 
associated with ADL functional decline (p=0.01).
Conclusions. There was a very high overall mortality of 42% 
in patients admitted to the general medical wards. Significant 
employment decline and readmission rates highlight the additional 
economic and societal burdens of hospitalisation due to medical 
illness in the survivors. 
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in whom death might have been anticipated within 12 months post 
discharge. Standardised prognostic indicator guidelines were used to 
identify these patients.4,5
Twelve-month follow-up
All patients’ contact details (identity numbers, telephone numbers 
and addresses) were obtained from the clinical records on the 
‘Clinicom’ system (Clinicom is the provincial hospital computer 
record-keeping system used at GSH) and from the patients’ folders, 
when otherwise unavailable. Additionally, Clinicom and/or the 
Western Cape provincial death registry was searched for details 
about patient mortality, date of death, hospital readmissions and/or 
outpatient clinic visits. Telephonic interviews were then attempted 
for all patients approximately 12 months following discharge from 
hospital. When patients were unable to be contacted by telephone, 
but had a valid address, a community healthcare worker undertook 
home visits. Patients unable to be contacted by any of the above 
methods were considered ‘lost-to-follow-up’.
Functional outcome assessments
Functional outcome assessments were conducted at either telephonic 
interview or a home visit. Where possible, patients were interviewed, 
but if unavailable, the interview was conducted with a first-degree 
relative with adequate knowledge of patient status. A standardised 
questionnaire in the patient’s/family member’s first language was 
used. Data collected included a pre- and post-admission Katz 
activities of daily living (ADL) scale and Barthel index (BI), pre- 
and post-admission employment and disability grant status, and 
post-discharge readmissions, as well as outpatient, emergency room 
and private doctor visits. Both the BI and Katz ADL scales are 
standardised, validated indices used to assess patient functionality 
and independence. The BI is an ordinal scale considering 10 factors; 
independence in basic living activities gives a score out of 90;6 the Katz 
Table 1. Demographic and basic clinical details for all study patients, and stratified by 12-month follow-up outcome
Patient demographics and 
clinical characteristics
All
(N=415) 
n (%)
Deceased
(N=145)
n (%)
Interviewed
(N=145)
n (%)
Untraceable 
(N=125)
n (%) p-value*
Age
Median (IQR) 44 (31 - 60) 50 (36 - 68)†1,†2 39 (29 - 56)†1 37 (29 - 52)†2 <0.001†1, <0.001†2
Female 224 (54) 74 (51) 84 (58) 69 (56) NS
Racial group
Black
White
Coloured
Other
216 (46)
36 (8)
204 (44)
9 (2)
51 (35)†1
8 (6)
83 (58)
3 (1)
65 (45)†2
12 (8)
63 (43)
5 (4)
75 (60)†1,†2
12 (10)
37 (30)
0 (0)
<0.001†1, 0.01*2
NS
NS
NS
Educational level
<5 years
5 - 7 years
>7 years
Unknown
57 (12)
48 (10)
262 (56)
98 (21)
19 (13)
21 (15)
74 (51)
31 (21)
16 (11)
11 (8)
98 (68)
29 (14)
16 (13)
13 (10)
77 (62)
19 (15)
NS
NS
NS
NS
HIV-positive 146 (31) 39 (27) 42 (29) 50 (40) NS
CD4, cells/ml (n=96)
Median (IQR) 111 (61 - 231) 72 (24 - 180)†1,†2 120 (73 - 256)†1 153 (65 - 302)†2 0.05†1, 0.05†2
Pre-admission HAART 56 (38) 15 (10) 17 (12) 20 (16) NS
Fully independent pre-admission ADL 298 (72) 97 (67)†1 103 (71) 98 (78)†1 0.04†1
Inpatient delirium 74 (16) 28 (20)†1 14 (10)†1 17 (14) 0.02†1
MEWS
Median(IQR) 2 (1 - 4) 2 (1 - 4) 2 (1 - 4) 2 (1 - 4) NS
Urea
Median (IQR) 6.6 (4.4 - 12.3) 7.9 (4.9 - 16.8)†1,†2 6.0 (4.1 - 10.4)†1 6.0 (3.9 - 10.1)†2 0.002†1, 0.002†2
Length of hospital stay 6 (4 - 11) 6 (3 - 10) 6 (3 - 10) 7 (4 - 12) NS
*p-values indicate significant differences between patient groups (marked with † to indicate comparison group) for demographic or clinical characteristics.
IQR = interquartile range; NS = not significant; HAART = highly active antiretroviral therapy; ADL = activities of daily living; MEWS = modified early warning score.
Fig. 1. Flow diagram indicating the 3 major 12-month follow-up outcomes.
465 new medical admissions (enrolled between 14 September and 16 November 2009)
415 patients eligible for follow-up
11% (50/465) inpatient 
mortality
Inclusion criteria:
(i) Age >16 years
(ii) Referred for medical ward admission
(iii) Verbal consent
Exclusion criteria:
(i) Patient requiring ICU admission
(ii) Refused consent
35%
(145/415)
35%
(145/415)30%
(125/415)
Home interviews: 9
Telephonic interviews: 136
No contact details: 54
Wrong or invalid number 
and no address details: 22
No answer or no address: 41
Failed home vist: 8
Deceased at 12 months
Median days to death 109 
IQR (37 - 246)
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ADL score, although similar to the BI, assesses 6 ADL and categorises 
patients A - G, with category A equating to full independence.7 
Statistical analysis
Simple descriptive statistics were employed and the 12-month 
deceased, untraceable and interviewed patient groups were compared 
using chi-squared and Kruskal-Wallis tests accordingly. Odds ratios 
(ORs) (95% confidence interval (CI)) were calculated for predictors 
of 12-month mortality (and unexpected 12-month mortality) as well 
as for an improvement or deterioration in functional status using 
logistic regression analysis. For this analysis, ‘untraceable’ patients 
were considered to be alive since their names could not be found in 
the provincial death registry. A change of one category and 5 points 
was considered clinically significant for the Katz ADL scale and BI, 
respectively. In the univariate analysis for predictors of overall and 
unexpected 12-month mortality, age and HIV-positivity were treated 
as potential confounders when considered to be independently 
associated with both the predictor and mortality, e.g. age and cancer, 
HIV and tuberculosis (TB). STATA IC, version 10 (Stata Corp, Texas, 
USA) was used for all statistical analyses. 
Results  
During the 9-week study period, 465 patients referred for admission 
to the acute general medical wards were enrolled. Eleven per cent 
(55/465) of patients died during hospital admission, and consequently 
12-month follow-up was attempted for 415 patients. Fig. 1 illustrates 
the 3 major follow-up outcome groups and details regarding each 
subgroup. Despite intensive efforts (including access to the provincial 
death registry), 30% (125/415) of patients could not be traced at 12 
months. There was no association between lower levels of education 
and ‘lost-to-follow-up’ category (p=0.98). However, being fully 
independent for ADL pre-admission and being of African race were 
associated with lost-to-follow-up (p=0.002 and p=0.01, respectively). 
Thirty-five per cent (145/415) of patients in the cohort were traced 
via telephonic interview or home visit.
Demographic and clinical details of all study patients, stratified 
by major outcome groups, are presented in Table 1. Overall, the 
median (interquartile range (IQR)) age was 44 (31 - 50), and racial 
and educational demographics reflected known provincial statistics. 
Patients who were deceased at 12-month follow-up were significantly 
older than both those interviewed and lost-to-follow-up (p<0.001). 
Thirty-one per cent (146/415) were known to be HIV positive with no 
differences in prevalence between outcome groups. In HIV-infected 
patients, the median (IQR) CD4 cell count was 111 (61 - 231).
Of the HIV-infected patients 38% (56/146) were receiving 
highly active antiretroviral therapy (HAART) pre-admission with 
no differences between groups. The majority of patients (72%) 
admitted to the hospital were fully independent prior to admission, 
and median (IQR) length of hospital stay was 6 (4 - 11) days. On 
admission, the median (IQR) modified early warning score (MEWS) 
was 2 (1 - 4); notably, scores were not significantly higher in patients 
deceased at 12-month follow-up. Only 14% (68/465) of patients were 
categorised as having a high-risk MEWS >5. However, inpatient 
delirium occurred in 20% (28/145) of deceased patients compared 
with only 10% (14/145) of those available for interviews (p=0.02). 
Twelve-month mortality in the study cohort was 35% (114/415). In 
the 80% (116/145) of patients where the date of death was known, the 
median (IQR) days-to-death was 109 (37 - 246) with 46% (53/116) of 
deaths occurring in the first 3 months following hospital discharge; 
38% (55/145) of 12-month mortality was anticipated by the discharge 
clinician (with 23% (34/145) of deceased patient folders not available 
for review). Combined inpatient and 12-month mortality was 42% 
(195/465). Table 2 illustrates demographic and clinical associations 
of 12-month mortality stratified by overall and unexpected 12-month 
mortality. Age >50 years, an admission urea >7 mmol/l and inpatient 
delirium were associated with an increased likelihood of 12-month 
mortality (p=0.01, p=0.007 and p=0.05, respectively). Additionally, 
a primary diagnosis of cancer and respiratory disease increased 
overall 12-month mortality (p=0.04 and p=0.05, respectively). The 
only demographic or clinical associations with unexpected 12-month 
mortality were age >40 years and admission urea >7.0 mmol/l 
(p=0.02 and p=0.004). No specific primary admission diagnosis 
or chronic underlying medical condition was associated with a 
significant increase in unexpected 12-month mortality. In HIV-
Table 2. Univariate demographic and clinical associations of 
12-month mortality*
Patient characteristics† Odds ratio (95% CI) p-value
All 12-month mortality (N=145)
Age >50 years 1.9 (1.2 - 3.0) 0.01
Urea >7.0 mmol/l 2.0 (1.2 - 3.2) 0.007
Inpatient delirium 2.1 (1.0 - 4.3) 0.05
Primary admission diagnosis‡
Cancer 9.3 (1.1 - 77.2) 0.04
Respiratory disease§ 8.5 (1.0 - 72.0) 0.05
TB 1.2 (0.5 - 2.7) 0.66
Main underlying chronic diagnosis¶
HIV-positive 1.5 (0.9 - 2.7) 0.15
If HIV-positive:
CD4 0.995 (0.989 - 0.999) 0.04
Cancer 4.6 (1.3 - 17.2) 0.02
Unexpected 12-month mortality (n=56)
Age >40 years 2.3 (1.1 - 4.5) 0.02
Urea >7.0 mmol/l 2.8 (1.0 - 5.7) 0.004
*Of the 145 patients in the cohort that were deceased at 12 months, folder discharge data 
were available for 110 patients only (35 folders missing).
†Age was treated as a potential confounder when evaluating all other variables.
‡Primary admission diagnosis was considered the patients’ reason for acute medical admission.
§Respiratory admission diagnoses included asthma and chronic obstructive pulmonary 
disease (COPD).
¶3/145 deceased patients had no underlying chronic diagnosis.
Fig. 2. Twelve-month follow-up changes in independent functioning 
as measured by the Katz and Bartel ADL indices and association with 
improvement or deterioration (only factors that were significantly associated 
with ADL improvement or worsening have been tabulated).TB and sepsis 
have been modelled with HIV as a potential confounder.
Barthel ADL (n=140) Katz ADL (n=143) 
Improved ADL 
No change in ADL 
Worsened ADL 
Improvement in Katz ADL index Improvement in Barthel ADL index
Variables Odds Ratio
(CI 95%)
p-value Variables Odds Ratio 
(CI 95%)
p-value
HIV 4.3 (1.9 - 9.9) 0.001 HIV 3.7 (1.7 - 8.3) 0.001
TB 2.5 (1.0 - 6.3) 0.040 TB 2.4 (1 - 5.7) 0.050
Sepsis 5.4 (1.2 - 23.4) 0.020 Sepsis 4.3 (1.0 - 18.1) 0.050
Worsening in Katz ADL index Worsening in Barthel ADL index
Age >50 years 4.1 (1.5 - 11.2) 0.005 Age >50 years 2.4 (1.1 - 5.3) 0.040
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infected patients, 12-month mortality was 27% (39/145), with the 
combined inpatient and 12-month mortality being 28% (54/195). 
HIV infection was not associated with an increased likelihood of 
12-month mortality (p=0.15).
Pre- and 12-month post-discharge functional ADL assessments 
using the Katz ADL scale and BI were completed for 143 and 140 
patients, respectively. Fig. 2 illustrates the changes between pre-
admission and 12-month ADL functionality for the two indices and 
the important admission determinants of worse, or improved, ADL 
functionality. Results were similar for both indices (51% and 62% 
of patients’ Katz ADL and BI scores, respectively, did not change 
from pre-admission levels); 23% and 26% of patients’ Katz ADL 
and BI scores, respectively, showed improvement at 12 months post 
discharge. Whether the BI or Katz ADL index was used, improvement 
in ADL functioning was associated with HIV positivity (Katz ADL 
OR (95% CI) 3.2 (1.3 - 7.7), p=0.01); the same proved true for an 
admission diagnosis of TB (Katz ADL OR (95% CI) 2.5 (1.0 - 6.3), 
p=0.04) or sepsis (Katz ADL OR (95% CI) 5.4 (1.2 - 23.4), p=0.02). 
In 15% and 23% of patients, Katz ADL and BI scores, respectively, 
had worsened at 12 months post discharge. A worsening ADL 
functionality, using either index, was associated only with an age >50 
years (Katz ADL OR (95% CI) 4.1 (1.5 - 11.2), p=0.005). 
At 12-month follow-up only 18% (27/145) of interviewed patients 
were in active employment compared with 33% (48/145) prior 
to hospitalisation (p=0.005). A worsening Katz ADL score was 
associated with employment loss (OR (95% CI) 3.0 (1.1 - 8.7), p=0.04). 
Despite the loss of employment among interviewed patients, there 
was not a significant increase in the number of people accessing 
disability grants (p=0.11). Of interviewed patients 19% (27/145) 
required readmission in the 12 months following discharge, with a 
median (range) of 1 (1 - 6) hospitalisations per patient. Additionally, 
47% (68/145), 5% (7/145) and 10% (15/145) of interviewed patients 
had accessed healthcare services in the form of outpatient consultations 
(range 4 - 10 occasions), emergency room visits (1 - 2) and private 
general practitioner consultations (1 - 3), respectively. A worsening 
Katz ADL score was associated with hospital readmission (OR (95% 
CI) 3.5 (1.3 - 9.2), p=0.01).
Discussion 
This is the first descriptive study of the 12-month outcomes of a 
cohort of patients admitted to an acute general medical service in a 
South African hospital. It highlights serious impacts deriving from 
severe medical illness that necessitates admission to hospital and 
important future implications for both the individual and public 
health. The key study findings were: (i) a very high 12-month 
mortality associated with known risk factors, but interestingly, not 
with HIV-infection; (ii) more than a third of 12-month mortality 
could be anticipated by clinicians at discharge, revealing the very 
high potential burden of patients on palliative care services, were 
they available, but who are accessing care as acute general medical 
admissions, and among whom (iii) approximately 20% required 
hospital readmission; (iv) an improvement in the ADL functioning of 
close to a quarter of patients interviewed at 12 months post discharge 
and the association of improvement with admission for chronic, but 
treatable, conditions such as HIV and TB; (v) a >80% reduction in 
employment rates associated with declining functionality; and (vi) 
the inability, despite modern record-keeping systems and household 
visits, to trace all patients.
While it is known that inpatient mortality in the general medical 
wards of GSH is approximately 10% (unpublished data), the 12-month 
mortality rates from acute general medical inpatient cohorts has not 
been previously established. The high 12-month mortality of 35%, 
and high combined overall cohort mortality rate of 42% (inpatient 
and outpatient 12-month deaths together), are comparable to those 
of follow-up studies of ICU cohorts in developed countries.1,8 This 
may be explained, in part, by the admission of a large number of 
patients with end-stage disease, who would fulfil criteria for referral 
to palliative care services. Unexpectedly, given that a third of patients 
were HIV-infected with a median CD4 cell count <200 cells/ml, 
and that less than half were receiving HAART pre-admission, HIV 
infection was found not to be associated with either an increased risk 
of overall or unexpected 12-month mortality. In fact, the inpatient 
mortality rate was lower than in a cohort of hospitalised HIV-infected 
patients with similar median CD4 counts in West Africa,9 and the 
12-month mortality rate was only marginally higher than the 5-year 
figures from a local primary care ARV-clinics study,10 reflecting the 
success of local infectious disease services and ARV-clinic treatment 
programmes. Moreover, an admission diagnosis of both HIV and TB 
infection was associated with improved functionality at 12 months 
in interviewed patients. These data suggest that patients deriving the 
greatest benefit from an acute hospital admission are those who are 
younger with acute deteriorations in chronic, yet treatable, conditions 
such as HIV and TB. 
South Africa’s inpatient medical services rival those in many 
developed countries, yet high lost-to-follow-up rates remain a 
major obstacle to ensuring high-quality long-term care. Patient 
migration and social and economic deprivation, together with 
inadequate record-keeping systems and personnel, mean that 
follow-up of patients with chronic and severe medical illness is a 
significant challenge. Lost-to-follow-up rates of between 5% and 
15% are not uncommon in research and community clinic settings 
in South Africa.11,12 From a public health perspective, the need 
for strengthening hospital record-keeping, as well as the human 
resources to improve service delivery, is exposed. 
Our study has a number of limitations. The large lost-to-follow-up 
number means that study conclusions regarding functional outcomes 
should be interpreted cautiously. Nonetheless, even if patients with 
expected mortality are removed, close to a third of cohort patients 
were deceased at 12 months. Moreover, important demographic 
and clinical characteristics (Table 1) did not differ significantly 
between the interviewed patients and those who were lost to follow-
up. Therefore, it is unlikely that the addition of these patients to 
the functional outcome data would have significantly altered our 
conclusions. Accuracy of follow-up data collected using telephonic 
interviews, despite being conducted in patients’ first language, is 
dependent on individual and/or family recall; this is an important 
study limitation, carrying the implication that hospital readmission 
rates and outpatient visits may be underestimates. 
This study clearly identifies patients admitted to general medical 
wards as a very high-risk group for early mortality. A larger study is 
required to identify clear predictors of unexpected early mortality. 
Until such data are available, it may be prudent that patients 
discharged from a tertiary hospital be cared for as a high-risk group, 
arguably, with specialist follow-up to ensure optimal post-discharge 
treatment care. At present, the majority of patients admitted to GSH’s 
general medical services are not afforded specialist follow-up after 
discharge, but are referred to their local community health centres. 
Whether more intensive follow-up (and the required resources that 
would be required) might reduce early mortality is a hypothesis 
that deserves to be tested. The requirement for improved palliative 
services for such patients is highlighted.
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